Fulminant necrotising amoebic colitis after corticosteroid therapy for severe COVID-19.
Renu SainiVivek Kumar BhagatBalamurugan ThirunavukkarasuAditya BaksiPublished in: BMJ case reports (2021)
Acute fulminant necrotising colitis is an uncommon presentation of amoebiasis, which can be precipitated after corticosteroid therapy. Clinicians treating patients with COVID-19 with corticosteroid therapy should be familiar with this condition to avoid delay in diagnosis. The disease is associated with high mortality, and prompt diagnosis and management are essential for salvaging patients. We report successful management of a patient who developed this complication following administration of steroids for COVID-19.
Keyphrases
- coronavirus disease
- liver failure
- sars cov
- end stage renal disease
- case report
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- palliative care
- stem cells
- early onset
- hepatitis b virus
- drug induced
- ulcerative colitis
- type diabetes
- risk factors
- cell therapy
- extracorporeal membrane oxygenation
- replacement therapy
- smoking cessation
- mechanical ventilation
- acute respiratory distress syndrome